Lynez C Preyan Selected Research

Aromatase (CYP19)

9/2013

Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynez C Preyan Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 12/2015 - 02/2013
2	Neoplasms (Cancer) 12/2015 - 02/2013
1	Carcinogenesis 02/2013

Drug/Important Bio-Agent (IBA)

2	Estrogens (Estrogen)FDA Link 12/2015 - 09/2013
2	Letrozole (Femara)FDA LinkGeneric 12/2015 - 09/2013
2	Aromatase InhibitorsIBA 12/2015 - 09/2013
2	Hormones (Hormone)IBA 09/2013 - 02/2013
1	glyceollinIBA 12/2015
1	Cadherins (E-Cadherin)IBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	Aromatase (CYP19)IBA 09/2013
1	PhytochemicalsIBA 02/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	PhytoalexinsIBA 02/2013
1	CurcuminIBA 02/2013
1	StilbenesIBA 02/2013

Therapy/Procedure

1	Therapeutics 12/2015